REBLOZYL® (luspatercept-aamt) logo for injection dosage 25mg and 75mg
BT & Anemia
BT & Anemia
Role of anemia in BT
Treating anemia in BT
About REBLOZYL
About REBLOZYL
REBLOZYL patient responses
Why REBLOZYL?
Starting &
Staying
Starting & staying on REBLOZYL
Starting REBLOZYL
Tracking your treatment
Resources
BT resources
Financial assistance
FAQ
Switch to REBLOZYL for MDS

References

swoosh

Important Safety Information | Contact Us | Privacy Policy | Your Privacy Choices | Legal Notice | Site Map

This website is intended for U.S. residents 18 years of age or older.

BMS Logo

REBLOZYL® is a trademark of Celgene Corporation, a Bristol Myers Squibb company.

Access Support® and Your REBLOZYL Connection™ are trademarks of Bristol-Myers Squibb Company.

REBLOZYL® is licensed from Merck & Co. Inc., Rahway, NJ, USA and its affiliates.

© 2025 Bristol-Myers Squibb Company.

2007-US-2500017  1/25